The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor

被引:156
作者
Marango, Jotin
Shimoyama, Manabu [3 ]
Nishio, Hitomi [2 ]
Meyer, Julia A. [1 ]
Min, Dong-Joon [1 ]
Sirulnik, Andres [4 ]
Martinez-Martinez, Yolanda
Chesi, Marta [5 ]
Bergsagel, P. Leif [5 ]
Zhou, Ming-Ming [6 ]
Waxman, Samuel
Leibovitch, Boris A.
Walsh, Martin J. [2 ]
Licht, Jonathan D. [1 ]
机构
[1] Northwestern Univ, Robert Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA
[2] Mt Sinai Sch Med, Dept Pediat, New York, NY USA
[3] Kobe Univ, Grad Sch Med, Div Hematol Oncol, Kobe, Hyogo, Japan
[4] Dana Farber Canc Inst, Div Hematol Malignancy, Boston, MA 02115 USA
[5] Mayo Clin, Scottsdale, AZ USA
[6] Mt Sinai Sch Med, Struct Biol Program, New York, NY USA
关键词
D O I
10.1182/blood-2007-06-092122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MMSET, identified by its fusion to the IgH locus in t(4;14)-associated multiple myeloma, possesses domains found within chromatin regulators, including the SET domain. MMSET protein is overexpressed and highly associated with chromatin in myeloma cell lines carrying t(4;14). MMSET possesses methyltransferase activity for core histone H3 lysine 4 and histone 4 lysine 20, whereas MMSET made in cells only modified H4. Segments of MMSET fused to the Gal4 DNA binding domain repressed transcription of a chromatin-embedded Gal4 reporter gene. MMSET-mediated repression was associated with increased H4K20 methylation gene and loss of histone acetylartion. Consistent with this repressive activity, MMSET could form a complex with HDAC1 and HDAC2, mSin3a, and the histone demethylase LSD1, suggesting that it is a component of corepressor complexes. Furthermore, MMSET coexpression enhances HDAC1- and HDAC2-mediated repression in transcriptional reporter assays. Finally, shRNA-mediated knockdown of MMSET compromised viability of a myeloma cell line, suggesting a biologic role for the protein in malignant cell growth. Collectively, these data suggest that, by acting directly as a modifier of chromatin as well as through binding of other chromatin-modifying enzymes, MMSET influences gene expression and potentially acts as a pathogenic agent in multiple myeloma.
引用
收藏
页码:3145 / 3154
页数:10
相关论文
共 45 条
[1]   Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [J].
Alland, L ;
Muhle, R ;
Hou, H ;
Potes, J ;
Chin, L ;
SchreiberAgus, N ;
DePinho, RA .
NATURE, 1997, 387 (6628) :49-55
[2]   Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1 [J].
Ananthanarayanan, M ;
Li, SD ;
Balasubramaniyan, N ;
Suchy, FJ ;
Walsh, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54348-54357
[3]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[4]   NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines [J].
Angrand, PO ;
Apiou, F ;
Stewart, AF ;
Dutrillaux, B ;
Losson, R ;
Chambon, P .
GENOMICS, 2001, 74 (01) :79-88
[5]   Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[6]  
BERGSAGEL P, 1996, P NATL ACAD SCI USA, P13931
[7]   RETRACTED: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus (Retracted Article) [J].
Bernard, D ;
Martinez-Leal, JF ;
Rizzo, S ;
Martinez, D ;
Hudson, D ;
Visakorpi, T ;
Peters, G ;
Carnero, A ;
Beach, D ;
Gil, J .
ONCOGENE, 2005, 24 (36) :5543-5551
[8]   The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant [J].
Chang, H ;
Sloan, S ;
Li, D ;
Zhuang, LH ;
Yi, QL ;
Chen, CI ;
Reece, D ;
Chun, K ;
Stewart, AK .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) :64-68
[9]   The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts [J].
Chesi, M ;
Nardini, E ;
Lim, RSC ;
Smith, KD ;
Kuehl, WM ;
Bergsagel, PL .
BLOOD, 1998, 92 (09) :3025-3034
[10]   A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma [J].
Dring, AM ;
Davies, FE ;
Fenton, JAL ;
Roddam, PL ;
Scott, K ;
Gonzalez, D ;
Rollinson, S ;
Rawstron, AC ;
Rees-Unwin, KS ;
Li, C ;
Munshi, NC ;
Anderson, KC ;
Morgan, GJ .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5692-5701